Item 71
approvedJun 25, 2025
Description
Authorize additional funding in the amount of $551,000 for prescription drug expenses to cover projected shortfalls for the remainder of fiscal year 2025. Effective upon G&C approval through June 30, 2025. 100% General Funds. Contingent upon Fiscal Committee approval on June 20, 2025.
Vote Record
approved
Motion by Liot Hill, seconded by Stevens acted as follows
Joseph Kenney
(R)
yes
Karen Liot Hill
(D)
yes
Janet Stevens
(R)
yes
John Stephen
(R)
yes
Dave Wheeler
(R)
yes
Documents (1)
Item_71.pdf
Open in new tab →